Vaccaro W D, Sher R, Davis H R
Schering-Plough Research Institute, Kenilworth, New Jersey 07033-0539, USA.
Bioorg Med Chem Lett. 1998 Jan 6;8(1):35-40. doi: 10.1016/s0960-894x(97)10185-8.
The asymmetric synthesis of a glucuronide conjugate of the 2-azetidinone cholesterol absorption inhibitor Sch 48461 was accomplished to confirm the structure of a metabolite isolated from in vivo sources. Key features of this article include the asymmetric synthesis of 2-azetidinones by Evan's chiral oxazolidinone methodology and glucuronide formation by a Mitsunobu protocol.
完成了2-氮杂环丁酮胆固醇吸收抑制剂Sch 48461的葡糖醛酸缀合物的不对称合成,以确认从体内来源分离出的一种代谢物的结构。本文的关键特征包括通过埃文斯手性恶唑烷酮方法进行2-氮杂环丁酮的不对称合成以及通过光延反应进行葡糖醛酸的形成。